Cargando…

The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment

Therapeutic resistance in glioblastoma multiforme (GBM) has been linked to a subpopulation of cells with stem cell-like properties, the glioma stem cells (GSCs), responsible for cancer progression and recurrence. This study investigated the in vitro cytotoxicity of three chemotherapeutics, temozolom...

Descripción completa

Detalles Bibliográficos
Autores principales:	ANNOVAZZI, LAURA, CALDERA, VALENTINA, MELLAI, MARTA, RIGANTI, CHIARA, BATTAGLIA, LUIGI, CHIRIO, DANIELA, MELCARNE, ANTONIO, SCHIFFER, DAVIDE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441296/ https://www.ncbi.nlm.nih.gov/pubmed/25892134 http://dx.doi.org/10.3892/ijo.2015.2963

Ejemplares similares

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

Stem Cell Niches in Glioblastoma: A Neuropathological View
por: Schiffer, Davide, et al.
Publicado: (2014)

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres
por: Caldera, Valentina, et al.
Publicado: (2011)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas
por: Caldera, Valentina, et al.
Publicado: (2008)

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2015)

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2018)

Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
por: Mellai, Marta, et al.
Publicado: (2013)

Comparison among conventional and advanced MRI, (18)F-FDG PET/CT, phenotype and genotype in glioblastoma
por: Valentini, Maria Consuelo, et al.
Publicado: (2017)

The Microenvironment in Gliomas: Phenotypic Expressions
por: Schiffer, Davide, et al.
Publicado: (2015)

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?
por: Mellai, Marta, et al.
Publicado: (2015)

Microglia immunophenotyping in gliomas
por: Annovazzi, Laura, et al.
Publicado: (2018)

SEL1L plays a major role in human malignant gliomas
por: Mellai, Marta, et al.
Publicado: (2019)

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
por: Clemente, Nausicaa, et al.
Publicado: (2018)

Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)

MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
por: Shah, Mrinal Y., et al.
Publicado: (2016)

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
por: Schiffer, Davide, et al.
Publicado: (2018)

Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas
por: Mellai, Marta, et al.
Publicado: (2020)

A Novel Blood-Brain Barrier-Permeable Chemotherapeutic Agent for the Treatment of Glioblastoma
por: Ozawa, Tomoko, et al.
Publicado: (2021)

REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
por: Conti, Luciano, et al.
Publicado: (2012)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma
por: Yu, Kenny Kwok-Hei, et al.
Publicado: (2018)

Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines
por: Maurici, Costanza E., et al.
Publicado: (2022)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Graphene Quantum Dots’ Surface Chemistry Modulates the Sensitivity of Glioblastoma Cells to Chemotherapeutics
por: Perini, Giordano, et al.
Publicado: (2020)

The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
por: Fink, D., et al.
Publicado: (1998)

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2020)

Effect of Various Chemotherapeutic Agents on Metastasis
por: Lapis, K., et al.
Publicado: (1956)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

Nail Changes Induced by Chemotherapeutic Agents
por: Saraswat, Neerja, et al.
Publicado: (2020)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage
por: Zhou, Qing, et al.
Publicado: (2016)

Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents’ Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2022)

Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
por: Sapino, Simona, et al.
Publicado: (2021)

Hyperthermia enhances the efficacy of chemotherapeutic drugs in heat-sensitive cells through interfering with DNA damage repair
por: Ni, Li-Ping, et al.
Publicado: (2022)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Carboplatin Plus Vincristine as an Alternative Chemotherapeutic Scheme in Patients With Glioblastoma
por: Sangrador-Deitos, Marcos V, et al.
Publicado: (2022)

Naked and Decorated Nanoparticles Containing H(2)S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells
por: Peira, Elena, et al.
Publicado: (2022)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
por: Frampton, Gabriel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_l433o5poguktvt1au5kg57u9f5